Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Chromatography Columns Market

ID: MRFR/HC/49851-HCR
200 Pages
Rahul Gotadki
Last Updated: April 02, 2026

South America Chromatography Columns Market Research Report By Column Type (Normal Phase Chromatography Columns, Pre-Packed Chromatography Columns, Automated Chromatography Columns), By Chromatography Type (Ion Exchange Chromatography, Affinity Chromatography, Gas chromatography, Gel Filtration Chromatography, Others), By Application (Anion and Cation Exchange, Sample Preparation, Resin Screening, Protein Purification, Desalting), By End User (Research Institutes, Pharmaceutical Biotechnology Companies, Food & Beverage Manufacturers, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Chromatography Columns Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Life Sciences, BY Column Type (USD Million) | |
      1. 4.1.1 Normal Phase Chromatography Columns | |
      2. 4.1.2 Prepacked Chromatography Columns | |
      3. 4.1.3 Automated Chromatography Columns |
    2. 4.2 Life Sciences, BY Chromatography Type (USD Million) | |
      1. 4.2.1 Ion Exchange Chromatography | |
      2. 4.2.2 Affinity Chromatography | |
      3. 4.2.3 Gas Chromatography | |
      4. 4.2.4 Size Exclusion Chromatography |
    3. 4.3 Life Sciences, BY Application (USD Million) | |
      1. 4.3.1 Anion & Cation Exchange | |
      2. 4.3.2 Sample Preparation | |
      3. 4.3.3 Resin Screening | |
      4. 4.3.4 Protein Purification | |
      5. 4.3.5 Desalting |
    4. 4.4 Life Sciences, BY End User (USD Million) | |
      1. 4.4.1 Research Institutes | |
      2. 4.4.2 Pharmaceutical Biotechnology Companies | |
      3. 4.4.3 Food & Beverage Manufacturers | |
      4. 4.4.4 Others 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Life Sciences | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Agilent Technologies (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Waters Corporation (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Merck KGaA (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 PerkinElmer (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Shimadzu Corporation (JP) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Sartorius AG (DE) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Bio-Rad Laboratories (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Jasco, Inc. (JP) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 SOUTH AMERICA MARKET ANALYSIS BY COLUMN TYPE |
    6. 6.3 SOUTH AMERICA MARKET ANALYSIS BY CHROMATOGRAPHY TYPE |
    7. 6.4 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    8. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USER |
    9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
    12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
    14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
    15. 6.12 LIFE SCIENCES, BY COLUMN TYPE, 2024 (% SHARE) |
    16. 6.13 LIFE SCIENCES, BY COLUMN TYPE, 2024 TO 2035 (USD Million) |
    17. 6.14 LIFE SCIENCES, BY CHROMATOGRAPHY TYPE, 2024 (% SHARE) |
    18. 6.15 LIFE SCIENCES, BY CHROMATOGRAPHY TYPE, 2024 TO 2035 (USD Million) |
    19. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
    20. 6.17 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
    21. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
    22. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY COLUMN TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Million) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

South America Life Sciences Market Segmentation

Life Sciences By Column Type (USD Million, 2025-2035)

  • Normal Phase Chromatography Columns
  • Prepacked Chromatography Columns
  • Automated Chromatography Columns

Life Sciences By Chromatography Type (USD Million, 2025-2035)

  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Gas Chromatography
  • Size Exclusion Chromatography

Life Sciences By Application (USD Million, 2025-2035)

  • Anion & Cation Exchange
  • Sample Preparation
  • Resin Screening
  • Protein Purification
  • Desalting

Life Sciences By End User (USD Million, 2025-2035)

  • Research Institutes
  • Pharmaceutical Biotechnology Companies
  • Food & Beverage Manufacturers
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions